Inflammatory signaling in human tuberculosis granulomas is spatially organized

Nature Medicine

Volumn 22, Issue 5, 2016, Pages 531-538

  Marakalala, Mohlopheni J ^a   Raju, Ravikiran M ^a   Sharma, Kirti ^b   Zhang, Yanjia J ^a   Eugenin, Eliseo A ^c,d   Prideaux, Brendan ^c   Daudelin, Isaac B ^c   Chen, Pei Yu ^c   Booty, Matthew G ^e,f   Kim, Jin Hee ^g   Eum, Seok Yong ^h   Via, Laura E ^i,j   Behar, Samuel M ^e   Barry, Clifton E ^i,j   Mann, Matthias ^b   Dartois, Véronique ^c,d   Rubin, Eric J ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g Masan National Hospital   (South Korea)

^h International Tuberculosis Research Center   (South Korea)

ⁱ NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^j UNIVERSITY OF CAPE TOWN   (South Africa)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ICOSANOID; LIPID; POLYPEPTIDE ANTIBIOTIC AGENT; PROTEIN; PROTEOME; REACTIVE OXYGEN METABOLITE; ARACHIDONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFOCAL MICROSCOPY; GRANULOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LASER CAPTURE MICRODISSECTION; MASS SPECTROMETRY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; LUNG TUBERCULOSIS; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; METABOLISM; PATHOLOGY; PROTEOMICS; RABBITS AND HARES; SIGNAL TRANSDUCTION;

ANIMALS; ARACHIDONIC ACID; EICOSANOIDS; GRANULOMA; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LASER CAPTURE MICRODISSECTION; MASS SPECTROMETRY; MICROSCOPY, CONFOCAL; PROTEOMICS; RABBITS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUBERCULOSIS, PULMONARY;

EID: 84962054174     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4073     Document Type: Article

References (50)

1. World Health Organization. World Health Organization tuberculosis fact sheet no. 104 (World Health Organization, 2015).
2. Taylor, J.L. et al. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74, 6135-6144 (2006).
3. Volkman, H.E. et al. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327, 466-469 (2010).
4. Ulrichs, T. et al. Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defense in the lung. J. Pathol. 204, 217-228 (2004).
5. Ehlers, S. & Schaible, U.E. The granuloma in tuberculosis: dynamics of a host-pathogen collusion. Front. Immunol. 3, 411 (2012).
6. Guirado, E. & Schlesinger, L.S. Modeling the Mycobacterium tuberculosis granuloma - the critical battlefield in host immunity and disease. Front. Immunol. 4, 98 (2013).
7. Mattila, J.T. et al. Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms. J. Immunol. 191, 773-784 (2013).
8. Ramakrishnan, L. Revisiting the role of the granuloma in tuberculosis. Nat. Rev. Immunol. 12, 352-366 (2012).
9. Cardona, P.-J. A spotlight on liquefaction: evidence from clinical settings and experimental models in tuberculosis. Clin. Dev. Immunol. 2011, 868246-868249 (2011).
10. Kim, M.-J. et al. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2, 258-274 (2010).
11. Kaplan, G. et al. Mycobacterium tuberculosis growth at the cavity surface: a microenvironment with failed immunity. Infect. Immun. 71, 7099-7108 (2003).
12. Subbian, S. et al. Lesion-specific immune response in granulomas of patients with pulmonary tuberculosis: a pilot study. PLoS One 10, e0132249 (2015).
13. Bold, T.D. & Ernst, J.D. Who benefits from granulomas, mycobacteria or host? Cell 136, 17-19 (2009).
14. Davis, J.M. & Ramakrishnan, L. The role of the granuloma in expansion and dissemination of early tuberculous infection. Cell 136, 37-49 (2009).
15. Peyron, P. et al. Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog. 4, e1000204 (2008).
16. Saunders, B.M. & Cooper, A.M. Restraining mycobacteria: role of granulomas in mycobacterial infections. Immunol. Cell Biol. 78, 334-341 (2000).
17. Via, L.E. et al. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using 2-[18F]fluoro-deoxy-d-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56, 4391-4402 (2012).
18. Lin, P.L. et al. Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing. Nat. Med. 20, 75-79 (2014).
19. Gideon, H.P. et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and anti-inflammatory cytokines is associated with sterilization. PLoS Pathog. 11, e1004603 (2015).
20. Mayer-Barber, K.D. et al. Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon cross-talk. Nature 511, 99-103 (2014).
21. Tobin, D.M. et al. Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections. Cell 148, 434-446 (2012).
22. Chen, M. et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death. J. Exp. Med. 205, 2791-2801 (2008).
23. Divangahi, M. et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair. Nat. Immunol. 10, 899-906 (2009).
24. Divangahi, M., Desjardins, D., Nunes-Alves, C., Remold, H.G. & Behar, S.M. Eicosanoid pathways regulate adaptive immunity to Mycobacterium tuberculosis. Nat. Immunol. 11, 751-758 (2010).
25. Serhan, C.N. Pro-resolving lipid mediators are leads for resolution physiology. Nature 510, 92-101 (2014).
26. Serhan, C.N., Chiang, N. & Van Dyke, T.E. Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat. Rev. Immunol. 8, 349-361 (2008).
27. Clay, H., Volkman, H.E. & Ramakrishnan, L. Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death. Immunity 29, 283-294 (2008).
28. Flynn, J.L. et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2, 561-572 (1995).
29. Dambuza, I. et al. Reactivation of M. tuberculosis infection in trans-membrane tumor-necrosis-factor mice. PLoS One 6, e25121 (2011).
30. Roca, F.J. & Ramakrishnan, L. TNF dually mediates resistance and susceptibility to mycobacteria via mitochondrial reactive oxygen species. Cell 153, 521-534 (2013).
31. Tobin, D.M. et al. The Lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans. Cell 140, 717-730 (2010).
32. Fallahi-Sichani, M., El-Kebir, M., Marino, S., Kirschner, D.E. & Linderman, J.J. Multiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation. J. Immunol. 186, 3472-3483 (2011).
33. Cilfone, N.A. et al. Computational modeling predicts IL-10 control of lesion sterilization by balancing early host-immunity-mediated antimicrobial responses with caseation during Mycobacterium tuberculosis infection. J. Immunol. 194, 664-677 (2015).
34. Cilfone, N.A., Perry, C.R., Kirschner, D.E. & Linderman, J.J. Multiscale modeling predicts a balance of tumor necrosis factor-α and interleukin-10 controls the granuloma environment during Mycobacterium tuberculosis infection. PLoS One 8, e68680 (2013).
35. McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O'Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87-103 (2015).
36. Prideaux, B. et al. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat. Med. 21, 1223-1227 (2015).
37. Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell. Proteomics 13, 2513-2526 (2014).
38. Prideaux, B. et al. High-sensitivity MALDI-MRM-MS imaging of moxifloxacin distribution in tuberculosis-infected rabbit lungs and granulomatous lesions. Anal. Chem. 83, 2112-2118 (2011).
39. Via, L.E. et al. A sterilizing tuberculosis treatment regimen is associated with faster clearance of bacteria in cavitary lesions in marmosets. Antimicrob. Agents Chemother. 59, 4181-4189 (2015).
40. Tobin, D.M. & Ramakrishnan, L. TB: the yin and yang of lipid mediators. Curr. Opin. Pharmacol. 13, 641-645 (2013).
41. Leong, F., Eum, S. & Via, L.E. in A Color Atlas of Comparative Pathology of Pulmonary Tuberculosis (eds. Leong, F.J., Dartois, V. & Dick, T.) 53-81 (CRC Press, 2011).
42. National Research Council. Guide for the Care and Use of Laboratory Animals 8th edn. (The National Academies Press, 2011).
43. Subbian, S. et al. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol. 1, 110016 (2011).
44. Ostasiewicz, P., Zielinska, D.F., Mann, M. & Wiœniewski, J.R. Proteome, phosphoproteome and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J. Proteome Res. 9, 3688-3700 (2010).
45. Sharma, K. et al. Quantitative analysis of kinase-proximal signaling in lipopolysaccharide-induced innate immune response. J. Proteome Res. 9, 2539-2549 (2010).
46. D'Souza, R.C.J. et al. Time-resolved dissection of early phosphoproteome and ensuing proteome changes in response to TGF-β. Sci. Signal. 7, rs5 (2014).
47. Michalski, A. et al. Mass-spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell. Proteomics 10, 011015 (2011).
48. Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794-1805 (2011).
49. Guan, Y.Q., Cai, Y.Y., Zhang, X., Lee, Y.T. & Opas, M. Adaptive correction technique for 3D reconstruction of fluorescence microscopy images. Microsc. Res. Tech. 71, 146-157 (2008).
50. Mietla, J.A. et al. Characterization of eicosanoid synthesis in a genetic ablation model of ceramide kinase. J. Lipid Res. 54, 1834-1847 (2013).